Intellia Therapeutics, Inc.
Total Trades
58
Buys
2
Sells
43
Largest Trade
N/A
Insiders
15
Institutional Funds
243
Inst. Value
$1M+
Activist Filings
19
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| BASTA JAMES | EVP, General Counsel | SELL | $15K–$50K | 1K | $13.78 | Mar 3, 2026 |
| BASTA JAMES | EVP, General Counsel | GRANT | N/A | 46K | — | Mar 3, 2026 |
| Clark Eliana | EVP | SELL | $1K–$15K | 607 | $13.78 | Mar 3, 2026 |
| Clark Eliana | EVP | GRANT | N/A | 7K | — | Mar 3, 2026 |
| LEONARD JOHN M | President and CEO | SELL | $100K–$500K | 34K | $9.21 | Jan 7, 2026 |
| Schultes Birgit C | EVP | SELL | $50K–$100K | 9K | $9.21 | Jan 7, 2026 |
| BASTA JAMES | EVP, General Counsel | SELL | $50K–$100K | 10K | $9.21 | Jan 7, 2026 |
| Cohen Fred E | Director | BUY | $1M+ | 150K | $9.35 | Jan 7, 2026 |
| Lebwohl David | EVP | SELL | $100K–$500K | 12K | $9.21 | Jan 7, 2026 |
| Clark Eliana | EVP | SELL | $50K–$100K | 10K | $9.21 | Jan 7, 2026 |
| Dulac Edward J III | CFO | SELL | $50K–$100K | 6K | $9.21 | Jan 7, 2026 |
| Dube Michael P | VP | SELL | $15K–$50K | 3K | $9.21 | Jan 7, 2026 |
| LEONARD JOHN M | President and CEO | EXERCISE | $100K–$500K | 59K | $6.83 | Dec 12, 2025 |
| LEONARD JOHN M | President and CEO | SELL | $500K+ | 88K | $9.49 | Dec 12, 2025 |
| CHASE WILLIAM J | Director | BUY | $1M+ | 100K | $10.03 | Aug 22, 2025 |
| Dulac Edward J III | CFO | SELL | $100K–$500K | 7K | $14.02 | Jul 25, 2025 |
| Clark Eliana | EVP | SELL | $1K–$15K | 1K | $9.82 | Jul 3, 2025 |
| Dube Michael P | VP | SELL | $15K–$50K | 3K | $9.95 | Jul 3, 2025 |
| GOODMAN JESSE | Director | SELL | $15K–$50K | 3K | $9.39 | Jul 2, 2025 |
| Bhanji Muna | Director | SELL | $1K–$15K | 265 | $8.50 | May 1, 2025 |
| Bhanji Muna | Director | SELL | $1K–$15K | 265 | $9.97 | Jan 31, 2025 |
| Dube Michael P | VP | SELL | $15K–$50K | 1K | $12.18 | Jan 7, 2025 |
| BASTA JAMES | EVP, General Counsel | SELL | $50K–$100K | 7K | $12.18 | Jan 7, 2025 |
| Lebwohl David | EVP | SELL | $100K–$500K | 10K | $12.18 | Jan 7, 2025 |
| Hicks Derek | EVP | SELL | $50K–$100K | 7K | $12.18 | Jan 7, 2025 |
| LEONARD JOHN M | President and CEO | SELL | $100K–$500K | 27K | $12.18 | Jan 7, 2025 |
| Sepp-Lorenzino Laura | EVP | SELL | $100K–$500K | 9K | $12.18 | Jan 7, 2025 |
| Clark Eliana | EVP | SELL | $50K–$100K | 8K | $12.17 | Jan 6, 2025 |
| Dube Michael P | VP | SELL | $15K–$50K | 2K | $19.01 | Oct 4, 2024 |
| Clark Eliana | EVP | SELL | $1K–$15K | 405 | $22.93 | Jul 3, 2024 |
| Verwiel Frank | Director | SELL | $15K–$50K | 2K | $25.00 | Jun 20, 2024 |
| Bhanji Muna | Director | SELL | $1K–$15K | 265 | $23.90 | Nov 2, 2023 |
| Bhanji Muna | Director | SELL | $1K–$15K | 265 | $42.33 | Aug 2, 2023 |
| Bhanji Muna | Director | SELL | $50K–$100K | 2K | $39.30 | Jul 10, 2023 |
| Clark Eliana | EVP | SELL | $1K–$15K | 360 | $40.51 | Jul 6, 2023 |
| Clark Eliana | EVP | SELL | $100K–$500K | 5K | $45.00 | Jun 22, 2023 |
| Clark Eliana | EVP | EXERCISE | $50K–$100K | 5K | $12.27 | Jun 22, 2023 |
| BASTA JAMES | EVP, General Counsel | SELL | $15K–$50K | 1K | $43.88 | Mar 3, 2023 |
| BASTA JAMES | EVP, General Counsel | GRANT | N/A | 37K | — | Mar 3, 2023 |
| Sepp-Lorenzino Laura | EVP | SELL | $100K–$500K | 5K | $37.82 | Jan 6, 2023 |
| LEONARD JOHN M | President and CEO | SELL | $100K–$500K | 7K | $37.21 | Jan 6, 2023 |
| Hicks Derek | EVP | SELL | $50K–$100K | 2K | $37.21 | Jan 6, 2023 |
| Lebwohl David | EVP | SELL | $50K–$100K | 3K | $37.21 | Jan 6, 2023 |
| Goddard Glenn | CFO | SELL | $50K–$100K | 2K | $37.21 | Jan 6, 2023 |
| Clark Eliana | EVP | SELL | $50K–$100K | 2K | $37.65 | Jan 6, 2023 |
| BASTA JAMES | EVP, General Counsel | SELL | $15K–$50K | 1K | $37.21 | Jan 6, 2023 |
| LEONARD JOHN M | President and CEO | SELL | $100K–$500K | 2K | $112.25 | Mar 5, 2022 |
| LEONARD JOHN M | President and CEO | GRANT | N/A | 41K | — | Mar 5, 2022 |
| LEONARD JOHN M | President and CEO | EXERCISE | N/A | 8K | — | Mar 5, 2022 |
| Sepp-Lorenzino Laura | EVP | EXERCISE | N/A | 4K | — | Mar 4, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 243 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| ARK Investment Management LLC | 14.2M | $1M+ | SH |
| VANGUARD GROUP INC | 12.1M | $1M+ | SH |
| STATE STREET CORP | 6.4M | $1M+ | SH |
| REGENERON PHARMACEUTICALS, INC. | 3.7M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3M | $1M+ | SH |
| Sumitomo Mitsui Trust Group, Inc. | 2.2M | $1M+ | SH |
| Amova Asset Management Americas, Inc. | 2.2M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 1.8M | $1M+ | SH |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.7M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 1.7M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 946K | $1M+ | SH |
| STIFEL FINANCIAL CORP | 931K | $1M+ | SH |
| HRT FINANCIAL LP | 765K | $1M+ | SH |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 731K | $1M+ | SH |
| Contrarius Group Holdings Ltd | 714K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 591K | $1M+ | SH |
| BARCLAYS PLC | 491K | $1M+ | SH |
| Vestmark Advisory Solutions, Inc. | 357K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 352K | $1M+ | SH |
| PEAK6 LLC | 347K | $1M+ | SH (Call) |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 12, 2026
2.7%
3.2M shares
Contrarius Investment Management Ltd
SC 13G/A · Feb 11, 2026
0.6%
714K shares
SC 13G · Feb 9, 2026
5.5%
6.4M shares
SC 13G/A · Feb 3, 2026
12.3%
14.2M shares
SC 13G/A · Jan 30, 2026
11.2%
13.0M shares
SC 13G · Nov 12, 2025
5.1%
5.5M shares
Contrarius Investment Management Ltd
SC 13G · Nov 12, 2025
5.5%
5.9M shares
SC 13G/A · Nov 4, 2025
11.1%
11.9M shares
SC 13G · May 13, 2025
4.4%
4.5M shares
SC 13G/A · Apr 17, 2025
8.2%
8.5M shares
SC 13G/A · Jan 8, 2025
10.0%
10.2M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.3%
8.3M shares
SC 13G/A · Jan 29, 2024
12.7%
11.4M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 24, 2024
5.3%
0 shares
SC 13G/A · Jan 8, 2024
10.1%
9.0M shares
SC 13G/A · Feb 10, 2023
11.2%
9.4M shares
SC 13G · Jan 25, 2023
8.7%
7.3M shares
Nikko Asset Management Americas, Inc.
SC 13G/A · Feb 14, 2022
3.7%
2.8M shares
REGENERON PHARMACEUTICALS, INC. 13-3444607
SC 13G/A · Feb 11, 2022
5.0%
3.7M shares